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INTRODUCTION
Aneurysms of the cerebral vasculature are relatively
common. A recent systematic review collecting data
from many countries reported a prevalence of 0.4% and
3.6% in retrospective and prospective autopsy studies,
respectively, and 3.7% and 6.0% in retrospective and
prospective angiographic studies, respectively (1).  The
angiographic studies likely overestimate the true
prevalence due to a selection bias, whereas the
retrospective autopsy studies likely underestimate the
true prevalence due to an inability to review the original
material.  Eighty-five percent of saccular aneurysms of
the cerebral vasculature occur in the circle of Willis (2).
Multiple aneurysms are seen in 30% of patients.  Most
are small and asymptomatic, but each year,
approximately 30,000 people in the United States suffer
a rupture, peaking in the sixth decade (3). When an
intracranial aneurysm ruptures, it may bleed into the
brain parenchyma resulting in a parenchymal
hemorrhage, or more often, it will bleed into the
subarachnoid space, resulting in a subarachnoid
hemorrhage (SAH).  A SAH is a catastrophic event with
a mortality rate of 25% to 50%.  Permanent disability
occurs in nearly 50% of the survivors, thus, only
approximately one-third of patients who suffer a SAH
have a positive outcome (3). 
RISK FACTORS
There are many risk factors for the development of
intracranial aneurysms, both inherited and acquired.
Females are more prone to aneurysm rupture, with SAH
1.6 times more common in women.  The prevalence of
aneurysms is increased in certain genetic diseases; the
classic example is autosomal dominant polycystic
kidney disease (ADPKD), but other diseases such as
Ehlers-Danlos syndrome, neurofibromatosis, and a1-
antitrypsin deficiency also demonstrate a link.  In
ADPKD, 10% to 15% of patients develop intracranial
aneurysms.  Marfan's Syndrome was once thought to be
linked to intracranial aneurysm formation, but recent
evidence suggests that this may not be true.  Aneurysms
also run in families in the absence of an identified
genetic disorder, with a prevalence of 7% to 20% in first
or second degree relatives of patients who have suffered
a SAH (2, 3).  The acquired risk factors are listed in
Table 1.
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Table 1. Acquired risk factors for intracranial aneurysms (4).
Increasing age
Hypertension
Smoking
Alcohol abuse
Estrogen deficiency
Hypercholesterolemia
Carotid artery stenosis
PATHOGENESIS
There are four main types of intracranial aneurysms:
saccular, fusiform, dissecting, and micotic type.  The
saccular type accounts for 90% of intracranial
aneurysms, thus, it will be the focus of this review.
Saccular aneurysms are a result of abberations to the
normal arterial structure, which consists of the tunica
intima adjacent to the lumen of the vessel, the tunica
media (the muscular middle layer), and the tunica
adventitia (the outer layer composed mainly of
connective tissue).  The internal elastic lamina delimits
the tunica intima from the tunica media, and the
external elastic lamina delimits the tunica media from
the tunica adventitia.  Saccular aneurysms occur when
there is collagen deficiency in the internal elastic lamina
and breakdown of the tunica media.  An outpouching,
consisting of only tunica intima and adventitia,
protrudes through the defect in the internal elastic
lamina and tunica media to produce the aneurismal sac
(5, 6).    The impaired integrity of the wall may be due
to congenital weakness or absence of the tunica media
or adventitia, degenerative alterations of the internal
elastic lamina (from hypertension, turbulent flow, or
atherosclerotic deposits in the wall), or both of these
factors combined (2).  Low collagen and elevated
plasma elastase has been observed in patients with
aneurysms, suggesting that vascular remodeling
involving collagen and elastin plays an important role
(4).
Eighty-five percent of saccular aneurysms arise from
the arteries of the circle of Willis.  The most frequent
location is the anterior communicating artery (35%),
followed by the internal carotid artery (30%-including
the carotid artery itself, the posterior communicating
artery, and the ophthalmic artery), the middle cerebral
artery (22%), and finally, the posterior circulation sites,
most commonly the basilar artery tip. See Figure 1 for a
scheme of the circle of Willis.  Multiple aneurysms are
found in approximately 30% of patients (2).
CLINICAL PRESENTATION
The symptoms of SAH result from blood spilling into
the cerebrospinal fluid (CSF) and the subsequent
increased intracranial pressure and breakdown of blood
products.  Characteristic symptoms include: "the worst
headache of my life," nausea and vomiting, loss of
consciousness, neck stiffness, and seizures (7, 8).  The
clinical manifestations of unruptured aneurysms,
however, are much more subtle. Only 10-15% of
intracranial aneurysms are symptomatic (9, 10), with
the majority being identified incidentally during
evaluation for other conditions.  When present, the
symptoms are primarily due to the mass effect of a large
aneurysm, or possibly from minimal leakage of blood
which irritates the meninges, though not enough to be
classified as a hemorrhage.  These symptoms include
headache, unilateral third cranial nerve palsy (from a
posterior communicating artery aneurysm), bilateral
temporal hemianopsia (from an anterior communication
artery aneurysm impinging on the optic chiasm)
ischemic cerebrovascular disease, poorly defined spells,
and seizures (4, 11).  These symptoms may be a warning
sign of an impending rupture, as 10% to 43% of patients
with SAH report experiencing a sentinel headache in
the 2 months preceding the rupture (12).
Table 2. Comparison of Sensitivity and Specificity of CTA, MRA,
and TCD in the diagnosis of intracranial aneurysms (4).
Method Sensitivity Specificity
CTA 90 86
MRA 87 95
TCD 82 95
DIAGNOSIS AND IMAGING FINDINGS
There are currently three imaging modalities widely
used in the diagnosis of intracranial aneurysms: intra-
arterial digital subtraction angiography (IADSA),
computed tomography angiography (CTA) and
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magnetic resonance angiography (MRA).  IADSA is
similar to conventional angiography in that a catheter is
advanced in the arterial system to the point of interest,
and radio-opaque contrast material is injected while
images are acquired.  The contrast fills the lumen of the
arteries; thus, the vessel anatomy is visualized on the
image.  In conventional angiography, serial x-ray films
are captured, while in IADSA, serial digital images are
obtained and stored on a computer.  An initial image
acquired before contrast injection is subtracted from the
post-contrast images.  The resultant image displays dark
vessels against a blank background (see Figure 2).  This
technique allows greater contrast resolution (the areas
with contrast are more obvious), but decreased spatial
resolution (because digitally acquired images have a
lower resolution than films) when compared with
conventional angiography.
CTA is another technique of vascular imaging which
involves obtaining a normal CT scan while intravenous
contrast material is injected.  The contrast material is
radio-opaque, so it appears white on the CT image.  The
serial axial slices enhanced with contrast are analyzed
by a computer program that forms a three-dimensional
reconstruction of the vascular anatomy.  The resultant
image is a dynamic model that can be rotated in order to
view the image from multiple perspectives (see Figure
3).
Table 3. The morbidity, mortality, and rebleeding rate
of intervention for intracranial aneurysms (3, 4, 23, 28)
Outcome Intravascular Coiling (%) Surgical Clipping (%)
Mortality 1.0-1.1 2.6-3.8
Morbidity 3.7-4.0 10.9-12.1
Rebleeding 2.6 0-0.9
Similar to CTA, MRA is a technique which uses serial
axial MRI images to form a three-dimensional
representation of the vascular anatomy.  Unlike CTA,
however, MRA does not require the use of intravenous
contrast material.  This is because the signal obtained in
magnetic resonance imaging depends on the magnetic
properties of the area being imaged.  A magnetic pulse
aligns all the protons in a certain area, and measuring
the amount of time necessary for those protons to return
to their pre-magnetization state generates the signal
which produces the MR image. With a moving
substance such as blood, the protons are aligned during
the magnetic pulse, but by the time the signal is
collected, the aligned protons have moved out of the
area which is being imaged, and new 'non-magnetized'
protons have taken their place.  Because these new
protons have not been magnetized, a signal is not
generated and the blood vessel lumen appears as a
'signal void' on the image (this is an oversimplified
explanation).  The lack of signal distinguishes the
vessels from the surroundings (see Figure 4).  In some
cases, a gadolinium contrast material may be used to
provide better imaging of the vessels.  The advantage of
MRA is that it can be used in patients who cannot
tolerate the iodine based contrast used in IADSA and
CTA, such as patients with allergic reactions or with
renal failure.
The gold standard for diagnosis of intracranial
aneurysms is currently IADSA, but a diagnosis can also
be provided by CTA and MRA.  The contrast provided
during IADSA causes the aneurysm to appear on
fluoroscopy as a radio opaque, smooth margined,
saccular out-pouching of the cerebral vasculature (see
Figure 2) (13).  A thrombus within the aneurismal sac
will be visualized as an interruption to the rounded
margin because contrast material will not penetrate the
clotted, stationary blood.  Such a thrombus will be
better delineated with CTA or MRA than IADSA, as
these former modalities image the vessel wall and
surroundings, not only the lumen of the vessel.  On
CTA, if large enough, an aneurysm will appear as a
rounded, spherical mass with attenuation (whiteness)
equal to that seen in the large vessels.  CT may also
depict calcifications in the wall of the aneurysm, or the
presence of thrombus within the lumen which will not
enhance with contrast medium; these characteristics are
seen more frequently in giant aneurysms (>25mm) (14).
On MRA, the lumen of the aneurysm will appear as a
flow void, meaning that it does produce a magnetic
signal because blood flow has slowed due to the larger
cross-sectional area of the aneurysms compared to the
nearby normal vasculature.  Areas of high signal
intensity surrounding the flow void area of the
aneurysm on MRA likely represent a rupture with
subsequent hemorrhage: the high signal pattern is
produced by stagnant blood (14).
As mentioned above, the gold-standard for diagnosis
of cerebral aneurysms is IADSA because it remains the
test with the highest spatial resolution.  But some cases
are not adequately visualized with IADSA alone, as
single projections do not provide a sense of volume, and
it may fail to detect an aneurysm if the lesion overlaps
with nearby vessels.  These concerns can be addressed
by using 3D rotational angiography, which images the
cerebral vasculature on many views.  However, IADSA
is costly and invasive with a 2-4% transient
complication rate and about 0.5% of patients
undergoing catheterization are left with permanent
neurological complications (15, 16, 17).  Typical
complications include amaurosis fugax, hemiparesis,Pathophysiology of Ischemic Injury 144 Vol. 9  No. 2
confusion, muscle spasm, and aphasia.  Because of
these considerations and the knowledge that CTA and
MRA are also effective tests, there is some debate over
the best way to diagnose an aneurysm (18, 19, 20).
Transcranial Doppler sonography has also been
proposed as a method to evaluate the presence of
aneurysms (21).  See Table 2 for the sensitivity and
specificity described for the various techniques.
However, it should be noted that these numbers are
based on studies with small sample sizes, and other
methodological flaws, and at this time, the available
data do not suggest that one modality is clearly superior
to the others (3).  It is also necessary to mention that the
values found in Table 2 are highly dependent on the size
of the aneurysm.  If the aneurysm is <3mm, the
sensitivity of MRA plummets to 38%, and the
sensitivity of CTA drops to 61% (2).  Because the
technology in radiological imaging is improving rapidly
with increases in resolution of all modalities, it is
expected that the values listed in Table 2 will improve
in the coming years.  Illustrating this point, a recent
study demonstrated CTA and IADSA to both have a
sensitivity of 97% and a specificity of 100% when
evaluating middle cerebral artery aneurysms.  In 76% of
the cases CTA was able to provide information not
available on IADSA, suggesting that CTA, in its current
state, may be superior to the "gold-standard" (22).
NATURAL HISTORY OF UNRUPTURED
INTRACRNIAL ANEURYSMS
There is a great deal of controversy surrounding the
natural history of unruptured aneurysms.  It is such a
hot-topic because knowing the likely course of
aneurysms will play a pivotal role in determining the
appropriate management.  Unlike the more predictable
course of abdominal aortic aneurysms, where the lesion
grows in size and rarely ruptures before it reaches the
threshold diameter of 5.0 cm, the data for intracranial
aneurysms are much less clear.
Prior to 1998, the data available estimated the rupture
rate for aneurysms to be 1 to 2.5% per year.  This value
indicates that over many years, the risk of rupture is
very significant, and therefore, surgical or endovascular
treatment is appropriate in patients with incidental
aneurysms (23).  However, in 1998, data published from
a study called the International Study of Unruptured
Intracranial Aneurysms (ISUIA) challenged many of
the beliefs about the natural history of aneurysms.  This
study had both retrospective and prospective parts.  The
retrospective part found that in patients whose
aneurysm measured <10mm and without a prior history
of SAH, the risk of rupture was 0.05% per year and the
risk of rupture for aneurysms >10mm was 1% per year
(24).  These data indicate that the rupture risk of
aneurysms may be much lower than what was
previously believed. This changes the recommendation
for intervention, because if the data from the ISUIA are
correct, the risk of intervention outweighs the risk of
rupture in small aneurysms.  The data from this study
also indicate that the size of the aneurysm is the best
predictor of future rupture, with 10mm appearing to be
an appropriate cut-off point between small and large
aneurysms.  The location of the lesion also had an
independent effect on the risk of rupture, with
aneurysms in the posterior circulation having a higher
risk (24).  In 2003, data from the prospective segment of
the study were published, and indicated the five-year
rupture risk is 0% and 2.5% for small aneurysms in the
anterior and posterior circulation, respectively. This
portion of the study also suggested that the upper limit
demarcation of a small aneurysm (thus, low of rupture)
is 7mm, not 10mm as suggested by the retrospective
segment of the ISUIA (25).
There are many criticisms of the ISUIA; a few of
which are subsequently discussed.  First, the patients
with unstable aneurysms were selected out of the
retrospective part of the study because they would have
been treated upon the discovery of the lesion, and not
included in the data.  Second, cavernous carotid
aneurysms were included in the study group, but these
lesions generally do not produce SAH.  Third, the
annual incidence of SAH in the United States is about
30,000, which can be calculated to a rupture rate of at
least 1% per year (23).  These points suggest that the
rupture rate suggested in the ISUIA may be artificially
low.
Despite these criticisms, this was indeed a landmark
study, and the clinical guidelines are based largely on
the data from this trial.  The current recommendations
are observation, rather than intervention, in patients
with incidental aneurysms <10mm.  Exceptions include
patients with growing lesions and those approaching
10mm, lesions with irregular morphological and
hemodynamic features, and patients with multiple first
or second degree relatives with a history of aneurismal
SAH.
MANAGEMENT
The appropriate management for unruptured
intracranial aneurysms does not have a clear evidence-
based strategy.  The risks of rupture must be weighed
against the risks associated with intervention. Three
main treatment options are available to the patient:
observation, endovascular therapy, and surgical therapy.
In light of the ISUIA data, observation is a viable
option in many cases.  If this management is selected, it
is important for the treating physician to be aware that
aneurysms may grow unpredictably, so it is necessary to145 2006 McGill Journal of Medicine
serially monitor the aneurysm and watch for new-onset
symptoms related to the aneurysm. Serial monitoring
can be accomplished non-invasively with MRA, CTA,
or possibly transcranial Doppler ultrasonography (see
section on diagnosis). The parameters suggesting that a
patient should not undergo intervention include: lack of
symptoms, aneurysm size <7mm, lesion in the anterior
circulation, age older than 64 years, and no personal or
family history of SAH.  Similarly, patients younger than
50 years with symptomatic aneurysms >25mm located
in the posterior circulation and a personal or family
history of SAH should undergo intervention (4).  Of
course, most cases fall somewhere in between these two
extremes and the appropriate management is not
obvious.
Approved by the FDA in 1991, endovascular
treatment consists of guiding a catheter from the
femoral artery to the cerebral vasculature via the ICA or
vertebral artery, depending on the location of the
aneurysm.  The procedure is guided by fluoroscopy, and
when the catheter has reached the aneurysm, several
soft platinum coils are deployed in the lumen of the
lesion.  These coils completely fill the lumen and induce
the formation of a thrombus to occlude the aneurysm,
preventing future rupture (4).  A wide neck and large
size of the aneurysm make the procedure more difficult
with poorer results. This procedure appears to be safe
relative to surgical treatment, and it is able to treat
lesions that are difficult to approach surgically, but there
are questions regarding the durability of the
endovascular technique.  In most studies, complete
occlusion is achieved in 80% to 90% of patients.  At
post-treatment follow-up, however, small neck
remnants are common, and some degree of thrombus
recanalization is observed in 50% of all patients and up
to 90% of patients with giant aneurysms.  Both neck
remnants and recanalization are associated with a risk
of rupture, and 20% of patients may require more than
one coiling procedure (23).  Contrast enhanced
transcranial Doppler sonography has been shown by a
small study to be sensitive and specific (100% and 97%,
respectively) in the detection of clinically relevant
residual flow in the follow-up of coil-embolized
aneurysms (26).  IADSA is effective in visualizing
treatment failures with residual necks or complete
recanalization, but 3D MR appears to be more effective
in evaluating "partial treatments" (27), such as
incomplete recanalization, which may prove to be
useful in detecting treatment failures before they have
the potential to hemorrhage.
Surgical clipping has been used for the treatment of
intracranial aneurysms for longer than 40 years.  This
procedure involves placing a surgical clip at the
junction of the healthy artery and the neck of the
aneurysm.  This treatment is very effective,
demonstrated by annual risks of rupture following
clipping reported from 0% to 0.9% (4,28). The
disadvantage is the invasive nature of the procedure,
which is associated with a higher risk of complications,
and as with any surgery, elderly patients are less able to
tolerate the trauma of the procedure.  See Table 3 for a
comparison of the two treatment interventions.
SUMMARY
Intracranial aneurysms are relatively common,
 
Figure 2. Bilobed aneurysm of the right middle cerebral artery
measuring 4x5mm.
 
Figure 3. Computed tomography (CT) angiography of the same
aneurysm depicted in Figure 2.
 
Figure 4. Magnetic resonance (MR) angiogram depicting normal
cerebral vasculaturePathophysiology of Ischemic Injury 146 Vol. 9  No. 2
occurring in approximately 4% of the population.  Most
of these aneurysms are asymptomatic, and they carry a
small but real risk of rupture, resulting in a
subarachnoid hemorrhage.  IADSA is the gold-standard
for diagnosis of intracranial aneurysms, but CTA,
MRA, and transcranial Doppler sonography are also
effective diagnostic tests.  These non-invasive imaging
modalities are more appropriate for serially monitoring
aneurysms because of the risks associated with invasive
angiography.  The natural history of intracranial
aneurysms is still being explored, but our current
understanding suggests that the annual risk of rupture is
1% or less.  Large, irregularly shaped lesions arising
from the posterior circulation are at an increased risk for
rupture.  The management strategies consist of
observation, intravascular coiling, and surgical clipping.
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